News

Whole blood RNA analysis offers the prospect of pathogen-free diagnosis to prevent, diagnose, and monitor infectious diseases and to identify individual timepoints to terminate antibiotic therapy. Encouragingly, colleagues working in the field of transcriptomic biomarker research make their data publicly available See Online for appendix to enable in-silico comparisons of validated signatures for their diagnostic and predictive performance in different manifestations of tuberculosis and different patient populations.